Targeting metastatic cancer

K Ganesh, J Massague - Nature medicine, 2021 - nature.com
Despite recent therapeutic advances in cancer treatment, metastasis remains the principal
cause of cancer death. Recent work has uncovered the unique biology of metastasis …

The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives

S Wang, Y Zheng, F Yang, L Zhu, XQ Zhu… - Signal transduction and …, 2021 - nature.com
Pancreatic cancer is an increasingly common cause of cancer mortality with a tight
correspondence between disease mortality and incidence. Furthermore, it is usually …

Reprogramming of fatty acid metabolism in cancer

N Koundouros, G Poulogiannis - British journal of cancer, 2020 - nature.com
A common feature of cancer cells is their ability to rewire their metabolism to sustain the
production of ATP and macromolecules needed for cell growth, division and survival. In …

Pioneer transcription factors initiating gene network changes

KS Zaret - Annual review of genetics, 2020 - annualreviews.org
Pioneer transcription factors have the intrinsic biochemical ability to scan partial DNA
sequence motifs that are exposed on the surface of a nucleosome and thus access silent …

Intratumor heterogeneity: the rosetta stone of therapy resistance

A Marusyk, M Janiszewska, K Polyak - Cancer cell, 2020 - cell.com
Advances in our understanding of molecular mechanisms of tumorigenesis have translated
into knowledge-based therapies directed against specific oncogenic signaling targets …

The epithelial–mesenchymal plasticity landscape: principles of design and mechanisms of regulation

J Haerinck, S Goossens, G Berx - Nature Reviews Genetics, 2023 - nature.com
Epithelial–mesenchymal plasticity (EMP) enables cells to interconvert between several
states across the epithelial–mesenchymal landscape, thereby acquiring hybrid epithelial …

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution

M Chan-Seng-Yue, JC Kim, GW Wilson, K Ng… - Nature …, 2020 - nature.com
Pancreatic adenocarcinoma presents as a spectrum of a highly aggressive disease in
patients. The basis of this disease heterogeneity has proved difficult to resolve due to poor …

Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis

C Burdziak, D Alonso-Curbelo, T Walle, J Reyes… - Science, 2023 - science.org
The response to tumor-initiating inflammatory and genetic insults can vary among
morphologically indistinguishable cells, suggesting as yet uncharacterized roles for …

Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches

M Orth, P Metzger, S Gerum, J Mayerle, G Schneider… - Radiation …, 2019 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with poor
prognosis and rising incidence. Late detection and a particularly aggressive biology are the …

A gene–environment-induced epigenetic program initiates tumorigenesis

D Alonso-Curbelo, YJ Ho, C Burdziak, JLV Maag… - Nature, 2021 - nature.com
Tissue damage increases the risk of cancer through poorly understood mechanisms. In
mouse models of pancreatic cancer, pancreatitis associated with tissue injury collaborates …